DE69627019D1 - PEPTIDKONJUGATE, DEREN VERWENDUNG ALS HEILMITTEL UND ZUSAMMENSeTZUNGen, DIEse ENTHALTENd - Google Patents

PEPTIDKONJUGATE, DEREN VERWENDUNG ALS HEILMITTEL UND ZUSAMMENSeTZUNGen, DIEse ENTHALTENd

Info

Publication number
DE69627019D1
DE69627019D1 DE69627019T DE69627019T DE69627019D1 DE 69627019 D1 DE69627019 D1 DE 69627019D1 DE 69627019 T DE69627019 T DE 69627019T DE 69627019 T DE69627019 T DE 69627019T DE 69627019 D1 DE69627019 D1 DE 69627019D1
Authority
DE
Germany
Prior art keywords
lys
lysine
conjugates
peptide conjugates
medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69627019T
Other languages
English (en)
Other versions
DE69627019T2 (de
Inventor
D Hinterland Lucien Dussourd
Anne-Marie Pinel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Europeen de Biologie Cellulaire
Original Assignee
Institut Europeen de Biologie Cellulaire
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Europeen de Biologie Cellulaire filed Critical Institut Europeen de Biologie Cellulaire
Application granted granted Critical
Publication of DE69627019D1 publication Critical patent/DE69627019D1/de
Publication of DE69627019T2 publication Critical patent/DE69627019T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4986—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with sulfur as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0819—Tripeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DE69627019T 1995-11-15 1996-11-15 PEPTIDKONJUGATE, DEREN VERWENDUNG ALS HEILMITTEL UND ZUSAMMENSeTZUNGen, DIEse ENTHALTENd Expired - Fee Related DE69627019T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9513543A FR2741075B1 (fr) 1995-11-15 1995-11-15 Conjugues peptidiques, leur utilisation a titre de medicament et compositions les contenant
FR9513543 1995-11-15
PCT/FR1996/001811 WO1997018235A1 (fr) 1995-11-15 1996-11-15 Conjugues peptidiques, leur utilisation a titre de medicament et compositions les contenant

Publications (2)

Publication Number Publication Date
DE69627019D1 true DE69627019D1 (de) 2003-04-30
DE69627019T2 DE69627019T2 (de) 2004-01-22

Family

ID=9484595

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69627019T Expired - Fee Related DE69627019T2 (de) 1995-11-15 1996-11-15 PEPTIDKONJUGATE, DEREN VERWENDUNG ALS HEILMITTEL UND ZUSAMMENSeTZUNGen, DIEse ENTHALTENd

Country Status (9)

Country Link
EP (1) EP0869969B1 (de)
JP (1) JP2000512613A (de)
AT (1) ATE235508T1 (de)
AU (1) AU7683196A (de)
CA (1) CA2237993A1 (de)
DE (1) DE69627019T2 (de)
ES (1) ES2193272T3 (de)
FR (1) FR2741075B1 (de)
WO (1) WO1997018235A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7001992B2 (en) 1997-05-30 2006-02-21 Human Genome Sciences, Inc. Antibodies to secreted protein HEMCM42
DE69841994D1 (de) * 1997-05-30 2010-12-23 Human Genome Sciences Inc 32 Humane sekretierte Proteine
FR2802413B1 (fr) * 1999-12-17 2003-10-31 Sederma Sa Compositions cosmetiques ou dermopharmaceutiques contenant le tripeptide n-palmytoyl-gly-hys-lys, pour eliminer, reduire ou prevenir l'apparition de rides quelles qu'en soient la localisation et la cause
FR2810323B1 (fr) * 2000-06-16 2002-09-06 Shiseido Int France Utilisation cosmetique d'un lipopeptide
KR100753472B1 (ko) 2002-03-15 2007-08-31 주식회사 엘지생활건강 사람 콜라겐 ⅰ형의 ｃ-말단에서 유래된 펩타이드에ｔａｔ 펩타이드가 결합된 융합 펩타이드, 이의 제조방법,및 이를 포함하는 피부주름개선 화장료 조성물
FR2857667B1 (fr) 2003-07-18 2007-07-13 Inst Europ Biolog Cellulaire Nouveaux conjugues peptidiques utiles dans le traitement preventif et curatif de l'alopecie
FR2857597B1 (fr) 2003-07-18 2008-01-25 Inst Europeen Biolog Cellulair Utilisation de conjugues peptidiques pour la preparation de compositions destinees au traitement preventif et curatif de l'alopecie.
DE602005025464D1 (de) 2004-03-26 2011-02-03 Dsm Ip Assets Bv Aminosäure- und peptid-konjugate von arylalkylsäuren zur verwendung in der kosmetik
FR2870244B1 (fr) * 2004-05-11 2011-01-07 Centre Nat Rech Scient Conjugues dipeptidiques antagonistes de l'alpha-msh
FR2913603A1 (fr) * 2007-03-15 2008-09-19 Michel Yvan Hocquaux Composition cosmetique destinee au soin de peaux agressees par un traitement esthetique tel qu'intervention chirurgicale,traitement lasers,dermabrasion,peeling.
CA2692190C (en) * 2007-06-29 2015-06-02 Innovactiv Inc. Novel compounds, use thereof in cosmetic and cosmeceutic applications, and compositions comprising same
WO2009003284A1 (en) * 2007-06-29 2009-01-08 Innovactiv Inc. Novel peptides, use thereof in cosmetic and cosmeceutic applications, and compositions comprising same
PL2165698T3 (pl) 2008-09-18 2017-01-31 Universkin Kompozycja kosmetyczna przeznaczona do pielęgnacji uszkodzonej skóry
US7928067B2 (en) 2009-05-14 2011-04-19 Ischemix Llc Compositions and methods for treating ischemia and ischemia-reperfusion injury
DE102009055970B4 (de) * 2009-11-27 2014-04-17 Marcus Asam Kosmetische Wirkstoffzubereitung
DK2640423T3 (en) 2010-11-18 2017-10-02 Ischemix Llc LIPOYL COMPOUNDS AND THEIR USE IN TREATMENT OF ISchemic DAMAGE
FR2986528B1 (fr) * 2012-02-06 2015-12-04 Inst Europeen Biolog Cellulair Nouveaux peptides antivieillissement
EP3615023B1 (de) 2017-04-25 2023-06-21 Ischemix LLC Lipoyl-glu-ala zur behandlung der neurodegenerativen verletzung

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5120831A (en) * 1985-02-08 1992-06-09 Procyte Corporation Metal-peptide compositions
US5118665A (en) * 1990-02-09 1992-06-02 Procyte Corporation Anti-oxidative and anti-inflammatory metal:peptide complexes and uses thereof
DE4127790A1 (de) * 1991-08-22 1993-02-25 Wank Anna Verwendung von oligopeptiden mit 2 bis 5 peptidbindungen fuer kosmetische zwecke und einige neue oligopeptid-metallkomplexe

Also Published As

Publication number Publication date
ES2193272T3 (es) 2003-11-01
AU7683196A (en) 1997-06-05
CA2237993A1 (fr) 1997-05-22
JP2000512613A (ja) 2000-09-26
WO1997018235A1 (fr) 1997-05-22
DE69627019T2 (de) 2004-01-22
EP0869969A1 (de) 1998-10-14
FR2741075A1 (fr) 1997-05-16
EP0869969B1 (de) 2003-03-26
ATE235508T1 (de) 2003-04-15
FR2741075B1 (fr) 1998-01-30

Similar Documents

Publication Publication Date Title
DE69627019D1 (de) PEPTIDKONJUGATE, DEREN VERWENDUNG ALS HEILMITTEL UND ZUSAMMENSeTZUNGen, DIEse ENTHALTENd
ATE217884T1 (de) Pentapeptid-methylester, die menschliche krebs hemmen
DE69428040T2 (de) Orale darreichungsform
DK1188768T3 (da) LHRH-antagonisk-peptider
ATE417622T1 (de) Regulation gastrointestinaler beweglichkeit
DE69327057T2 (de) Polyarylate, die derivate der natürlichen aminosäure l-tyrosin enthalten
ATE308998T1 (de) Langwirkende arzneistoffe und diese enthaltende arzneimittel
FR2710340B1 (fr) Dérivés peptidiques de l'alpha-MSH et leur application .
ATE238348T1 (de) Aus thymischen hormonen abstammende peptid konjugierte, deren verwendung als medikamente und aus deren enthaltende zusammensetzungen
ATE196296T1 (de) Dolastatin analog
ATE94869T1 (de) Diphenylheteroalkylderivate, ihre herstellung und daraus hergestellte arzneimittel und kosmetika.
RS49772B (sr) Farmaceutske kompozicije
ATE93527T1 (de) Peptide und deren benutzung.
ITMI913510A0 (it) Composizioni farmaceutiche contenenti progesterone ad elevata biodisponibilita'
NO982227L (no) Urogenitalcarcinom-TPL komplekspeptider og antistoffer derav
SE9101586D0 (sv) Modified thioredoxin and its use
MX9604539A (es) Aminoacidos modificados para la distribucion de farmaco.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee